Items where Author is "Ananworanich, J."
Jump to: 2008 Number of items: 3. 2008Ananworanich, J. and Nuesch, R. and Côté, H. C. and Kerr, S. J. and Hill, A. and Jupimai, T. and Laopraynak, N. and Saenawat, S. and Ruxrungtham, K. and Hirschel, B.. (2008) Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine : a Staccato trial substudy. Journal of Antimicrobial Chemotherapy, Vol. 61. pp. 1340-1343. Nüesch, R. and Ananworanich, J. and Srasuebkul, P. and Chetchotisakd, P. and Prasithsirikul, W. and Klinbuayam, W. and Mahanontharit, A. and Jupimai, T. and Ruxrungtham, K. and Hirschel, B.. (2008) Interruptions of tenofovir/emtricitabine-based antiretroviral therapy in patients with HIV/hepatitis B virus co-infection. AIDS, Vol. 22. pp. 152-154. Ananworanich, J. and Gayet-Ageron, A. and Ruxrungtham, K. and Chetchotisakd, P. and Prasithsirikul, W. and Kiertiburanakul, S. and Munsakul, W. and Raksakulkarn, P. and Tansuphasawadikul, S. and LeBraz, M. and Jupimai, T. and Ubolyam, S. and Schutz, M. and Hirschel, B. and Staccato, Thailand Study Group. (2008) Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir. Antiviral therapy, Vol. 13. pp. 375-380. |
